This trial will test if using a heart pump called Impella during high-risk heart procedures helps improve symptoms, heart function, and health better than the current standard of care.
2 Primary · 12 Secondary · Reporting Duration: 3 years
Active Control
Experimental Treatment
1252 Total Participants · 2 Treatment Groups
Primary Treatment: Impella CP® / Impella CP® with SmartAssist® / Impella 2.5® · No Placebo Group · N/A
Age 18 - 90 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:New Jersey | 100.0% |
18 - 65 | 100.0% |
Robert Wood Johnson Medical School & Robert Wood Johnson University Hospital | 100.0% |
Did not meet criteria | 100.0% |